Immunology Drugs

398 FDA-approved drugs

TheraRadar tracks 398 FDA-approved immunology drugs from 179 companies across 50 drug classes, led by Novartis, with 1,426 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Immunology.

Upcoming Immunology Phase 3 readouts →

Immunology Approvals by Year

4

'15

8

'16

10

'17

10

'18

9

'19

8

'20

11

'21

9

'22

14

'23

20

'24

9

'25

1

'26

Recent Immunology Drug Approvals

ICOTROKINRA HYDROCHLORIDE

moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who w...

Johnson & Johnson

NARSOPLIMAB-WUUG

adult and pediatric patients 2 years of age and older with hematopoietic stem cell transplant-associ...

chronic spontaneous urticaria (CSU) in adult patients who remain symptomatic despite H1 antihistamin...

adult patients and pediatric patients 6 years of age and older and weighing at least 20 kg with acti...

adult patients with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient...

the management of acute pain or treatment of primary dysmenorrhea...

CARWIN PHARM ASSOC

GARADACIMAB-GXII

prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 1...

USTEKINUMAB-HMNY

adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...

BIO-THERA SOLUTIONS LTD

NIPOCALIMAB-AAHU

generalized myasthenia gravis (gMG) in adult and pediatric patients 12 years of age and older who ar...

Johnson & Johnson

TOCILIZUMAB-ANOH

adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate re...

USTEKINUMAB-STBA

adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...

CELLTRION, INC.

USTEKINUMAB-KFCE

adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...

BIOCON BIOLOGICS INC

USTEKINUMAB-SRLF

adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...

ACCORD BIOPHARMA INC.

USTEKINUMAB-AAUZ

adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...

LEBRIKIZUMAB-LBKZ

adults and pediatric patients 12 years of age and older who weigh at least 40 kg with moderate-to-se...

axatilimab-csfr

chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic ther...

NEMOLIZUMAB-ILTO

adults with prurigo nodularis...

GALDERMA LABS LP

emergency treatment of type I allergic reactions, including anaphylaxis, in adult and pediatric pati...

ARS PHARMS OPERATION

DEURUXOLITINIB PHOSPHATE

adult patients with severe alopecia areata...

Aurobindo Pharma

Showing the 20 most recent of 398 immunology drugs. View all 398 →

Top Immunology Companies

Novartis 19 Pfizer 19 Merck 17 AbbVie 13 Johnson & Johnson 10 Bayer 10 Teva 9 BAUSCH 8 SOLVAY 8 Amgen 7

Immunology Active Trials by Indication

1,426 active trials — the forward pipeline, not just approvals.

Lupus 243 Atopic Dermatitis 169 Ulcerative Colitis 156 Rheumatoid Arthritis 150 Crohn's Disease 147 Psoriasis 132 Myasthenia Gravis 78 IgA Nephropathy 73

All competitive landscapes →

Immunology Drug Classes

Nonsteroidal Anti-inflammatory Drug 14

Tumor Necrosis Factor Blocker 12

Corticosteroid 12

Interleukin-12 Antagonist 7

Complement Inhibitor 7

Calcineurin Inhibitor Immunosuppressant 7

Aminosalicylate 7

Interleukin-6 Receptor Antagonist 5

Vitamin D Analog 5

Kinase Inhibitor 4

Immunology at a Glance

Total Drugs: 398
Companies: 179
Drug Classes: 50
Active Trials: 1,426
Latest Approval: 2026-03-17